ABSTRACT Increased demand for the production of human biopharmaceuticals in transgenic organisms has led to an intensive effort to develop the hen as a bioreactor producing exogenous proteins in egg white via transgenesis. To date, however, robust methods for transgenic modification of the avian genome have been lacking. We have used a replication-defective retroviral vector derived from avian leukosis virus (ALV) to generate transgenic chickens expressing bacterial β-lactamase secreted into
INTRODUCTION
In 1980 and 1981, two seminal papers reported that transgenic mouse embryos could be generated by microinjection of DNA into pronuclei (Gordon et al., 1980) , which, when taken to term, yielded transgenic mice stably harboring the transgene in their genetic material and demonstrated germline transmission of foreign DNA (Gordon and Ruddle, 1981) . Combined with reports that Escherichia coli could synthesize the mammalian proteins, rat growth hormone (Seeburg et al., 1978) and human proinsulin (Villa-Komaroff et al., 1978) , it was a logical step to use higher organisms or their cells for the production of human biopharmaceuticals in transgenic animals. Development of an alternative bioreactor to E. coli proved critical when it became clear that the bacterium was limited in its ability to produce commercially valuable eukaryotic proteins because when highly expressed most proteins formed insoluble inclusion bodies (Harris, 1983; Williams et al., 1982) . Furthermore, bacteria are unable to carry out critical posttranslational modifications, especially glycosylation.
Among large mammals, the focus was on the mammary gland and mammary gland-specific promoters to drive expression. Expression of foreign proteins in livestock milk was first reported for transgenic dairy cattle (Pursel, 1989) followed quickly by similar accomplishments in transgenic To whom correspondence should be addressed: ivarie@uga.edu. 927 serum and egg whites through several generations. Expression was driven by the ubiquitous cytomegalovirus (CMV) promoter. Here we describe results from a transgenic lineage (Harvey et al., 2002a,b) in which (1) the transgene was stably transmitted from a G1 founder male (5657) through several generations without silencing, (2) the protein was biologically active, and (3) the level of expression in egg whites was doubled in a G3 homozygote.
goats Ebert et al., 19910, sheep (Wright, 1991) , and swine (Paleyanda, 1997) . These are attractive models because of the high level of expression and large volumes of milk produced by the transgenic animals. However, long generation times are a significant disadvantage for scalability. Purification of foreign protein from milk is quite expensive requiring removal of high levels of fat, liquid, and endogenous proteins. Furthermore, a large class of biopharmaceuticals may not be able to be produced in mammals because leaky promoters and evolutionary conservation of function are likely to yield lethal levels of some proteins such as growth factors and cytokines.
The hen, however, sidesteps many of these problems. A large grade A egg white egg contains on average 3.5 g of protein, half of which comes from two ovalbumin alleles, which are expressed specifically in tubular gland cells of the oviduct magnum. The generation time is relatively short (21 d to hatch and 6 mo to sexual maturity and egg production), modern layers lay up to 330 eggs annually, transgenic flocks are readily scalable via artificial insemination, egg whites are naturally sterile, and a vast infrastructure is in place in the egg layer industry for automated egg collection, cleaning, cracking, and egg white separation. More importantly, current good manufacturing practice (cGMP) production of over 300 million measles vaccines in fertilized eggs for use in humans has laid the Abbreviation Key: ALV = avian leukosis virus; CMV = cytomegalovirus; LTR = long terminal repeat; REV = reticuloendotheliosis virus. regulatory foundation for FDA approval of human biopharmaceuticals in eggs.
Although a few transgenic birds with germline transmission have been produced by DNA microinjection into freshly fertilized oocytes (Love et al., 1994; Sherman et al., 1998) , most transgenic birds have come from the use of retroviral vectors. In the first instance, replication competent avian leukosis virus (ALV) was used to infect stage X blastodermal cells of freshly laid eggs generating G0 transgenic offspring with germline transmission (Salter et al., 1986 (Salter et al., , 1987 . Such birds were viremic and unsuitable for production of pharmaceuticals. To avoid this problem, a replication-deficient reticuloendothelial virus (REV) was developed that yielded many transgenic birds (Bosselman et al., 1989) . Apparently, however, the REV vector generated viremic birds and was inappropriate for commercialization.
We chose to use the ALV-based vector, which has been shown to be replication-defective and does not produce infectious ALV virus in transgenic birds (Cosset et al., 1990; Thoraval et al., 1995) . Although the frequency of germline transmission was very low, methods developed for high throughput transgene screening obviated this problem (Harvey et al., 2002a ). Here we describe results from one lineage of transgenic birds expressing secreted β-lactamase in egg white via the ALV retroviral vector system. The transgene was stably expressed through several generations, and the level of expression was increased twofold in a single G3 transgenic hen.
MATERIALS AND METHODS

Construction of the Vector, Production of Transduction Particles and Transgenic Chickens, and Assay for β-Lactamase
Methods for constructing the vector (Figure 1 ) via the modified NLB plasmid, generation of transducing particles to yield transgenic birds, and the assay for biologically active β-lactamase have been described in detail previously (Harvey et al., 2002a,b) . In short, the expression vector was transfected into the first packaging cell line, Isolde, followed by transduction into the second packaging line, Senta. Transducing particles were concentrated from the cell medium by centrifugation, and approximately 50,000 particles were injected into the subgerminal cavity beneath the stage X blastoderm. Windows were sealed as described with hatch rates in excess of 30% (Speksnijder and Ivarie, 2000) . Blood from hatchlings taken from a wing vein was used to assay enzyme levels in serum and to extract DNA and screen for the transgene using the Taqman assay (Harvey et al., 2002a) . One G0 rooster (2395) was positive for the transgene and was crossed to a nontransgenic female yielding the transgenic G1 rooster 5657. G2 females produced from this male by crossing to nontransgenic hens were allowed to reach sexual maturity, and their eggs were screened for the presence of β-lactamase in their egg whites using an histochemical enzyme assay (Moore et al., 1997) that was modified (Harvey et al., 2002b) . Levels of enzyme The 5′ and 3′ long terminal repeats (LTR), the cytomegalovirus (CMV) promoter, and the poly-A signal sequence (pA) are shown along with the neomycin-resistance (neo′) and β-lactamase genes (BL). The lineage giving rise to G1 hemizygous hen 5657 and her subsequent progeny is shown in panel B. Serum from representative transgenic G2 progeny were assayed for enzyme levels and compared to hen 5657 (panel C) For serum levels, enzyme activity is the average of three determinations. units were converted to mass units by normalization levels for purified enzyme. Figure 1 shows the transgene construct (1A) and the lineage of transgenic hen 5657 (1B). She was one of three offspring produced by the G0 mosaic sire 2395 after mating to a nontransgenic hen. Results for the lineage of rooster 4133 have been described in detail (Harvey et al., 2002b) . Offspring of G1 rooster 5308 lacked detectable levels of β-lactamase in serum and were not analyzed further. This is the only example of possible gene silencing observed so far among all transgenic progeny derived from G0 male 2395.
RESULTS AND DISCUSSION
Lineage of G1 Transgenic Hen 5657 and Expression Levels of G2 Offspring
As previously shown by Southern blot analysis (Harvey et al., 2002a) , the transgene was integrated in the genetic FIGURE 2. Egg white levels of β-lactamase in hen 5657 and her G2 progeny and stability of expression in eggs of hen 5657. Egg white from representative transgenic G2 progeny were assayed for enzyme levels (panel B) and compared to hen 5657 (panel A). In panel A, eggs from 5657 were collected intermittently over a 9-mo period and assayed for enzyme levels. For egg white levels, the value is the average of three different eggs. In panel C, the levels of enzyme were measured in egg whites from three eggs collected from homozygous hen 6978 and compared to the average level of G2 hemizygotes (1.8 ± 0.02). The control value is from a nontransgenic hen.
material of 5657 at a single site and segregated in a Mendelian manner. G1 hens were generated by crossing to a nontransgenic male; those expressing β-lactamase in their serum were grown to sexual maturity, and their egg whites were assayed for levels of enzyme. The levels of enzyme in serum ( Figure 1C ) increased about twofold between the G1 and G2 generations among the G2 hens. The reason for this discrepancy is twofold: (1) the eggs for the G1 offspring were collected at the same time shortly after they began laying whereas dam 5657 was considerably older at the time of collection, and (2) serum levels are initially high and then taper off to a relatively constant level as the hens age (data not shown). A similar but less pronounced result was also observed or dam 5657's egg white levels in Figure  2A as reported for egg white levels of G2 hens sired by transgenic 4133 rooster (Harvey et al., 2002b) . Nonetheless, the levels of the enzyme in egg whites ( Figure 2B ) were similar for 5657 and her female offspring ranging from 0.13 to 0.20 µg/mL.
To determine whether β-lactamase levels would double in homozygotes, two siblings, hen 8617 and rooster 8839, were crossed to yield a single female homozygote (6968).
The hen was confirmed to be a homozygote by Taqman analysis as well as by Southern blotting (Harvey et al., 2002a) . As shown in Figure 2C , the levels of enzyme in her egg white increased about twofold over the average of 0.18 ± 0.02 µg/mL observed in G2 hemizygous hens. In this experiment, data from eggs collected at the same ages were compared. Unfortunately, 6968 was the only female homozygote obtained in this small cross so we cannot determine how general the conclusion will be.
Comparison of Expression Data for the 4133 and 5657 Lineages
There are two major differences between the experimental findings for the two lineages. First, the level of egg white expression of 5657 progeny was about 10-fold less than that of 4133 progeny. Second, within a generation for eggs collected at the same age, the level of expression was more predictable for 5657 progeny than for 4133 progeny. Although the reasons for this finding are unknown, it is likely that a major contributing factor involves effects on expression from the sites of integration (Emerman and Temin, 1984) . In this view, the transgene is subject to variable repression by elements near its site of integration in 4133, and this effect is observed between generations after gametogenesis. For 5657, the site of integration may not significantly influence the transcription of the transgene between generations.
An additional factor affecting expression levels could be interference between the 5′ long terminal repeat (LTR) promoter and the internal CMV promoter. For example, in cell culture experiments the internal promoter of an integrated retrovirus can be suppressed by the 5′ LTR promoter if the 5′ LTR promoter is transcriptionally active and vice versa (Emerman and Temin, 1984) . Inhibition or activation of either promoter, which can occur to different degrees, could be reversed by release of the provirus from the cellular genome or passaging cell clones. Although the mechanism is uncertain, the local chromosomal environment could determine the extent of interaction between the promoters. Significant silencing or activation of the CMV promoter was not observed in successive generations of transgenic chickens (Harvey et al., 2002b) . Regardless, a combination of position-dependent effects and epigenetic promoter interference might account for the variable egg lactamase levels observed in the different G2 and G3 hens bred from G1 rooster 4133.
Although based on only a single observation in a small breeding experiment, it was interesting to find that the level of egg white enzyme doubled in a homozygote compared to the average level of its G1 hemizygotes. Although not unexpected, a simple way to double the level of exogenous proteins in egg white would be to create homozygous flocks.
Finally, the levels of expression are far below those required for commercialization and an intense effort is underway to develop promoters driving much higher levels of expression. Nonetheless, these experiments provide proof of the concept that a foreign protein can be expressed in a biologically active form in the oviduct and secreted stably into the egg white. As noted before (Harvey et al., 2002b) , the egg white is a natural "container" for foreign proteins because of its sterility and high protein concentration that protects even dilute protein from denaturation.
